Selective Use of Inpatient Interstage Management After Norwood Procedure
Autor: | Nancy Rudd, Jena Tanem, Michele A. Frommelt, Garick D. Hill, Julie Lavoie, Nicholas J. Ollberding, Nancy S. Ghanayem |
---|---|
Rok vydání: | 2019 |
Předmět: |
Pulmonary and Respiratory Medicine
Heart Defects Congenital Male medicine.medical_specialty medicine.medical_treatment Logistic regression Norwood Procedures Article Bidirectional Glenn procedure Medicine Humans Survival rate Retrospective Studies Inpatient care business.industry Infant Retrospective cohort study Patient Discharge Hospitalization Survival Rate Treatment Outcome Glenn procedure Emergency medicine Cohort Surgery Norwood procedure Female Cardiology and Cardiovascular Medicine business |
Zdroj: | Ann Thorac Surg |
ISSN: | 1552-6259 |
Popis: | We report our intermediate-term results after Norwood procedure, including use of an interstage inpatient management strategy for high-risk patients, and seek to create a predictive model for probability of discharge.A single-site retrospective review was conducted for all patients undergoing Norwood procedure from 2006 to 2016 (N = 177). We compared those discharged home with those who either remained hospitalized until Glenn procedure or died before Norwood procedure discharge. Multivariable logistic regression was used to develop a predictive model for discharge.During the study period, 120 (68%) patients were discharged home, 45 (25%) remained hospitalized, and 12 (7%) died before Glenn procedure (median age: 71 days). Interstage survival for those discharged after Norwood procedure was 100%. Longitudinal survival for the cohort was 86%, 81%, and 77% at 1, 5, and 10 years, resepectively. Ten-year survival was significantly greater for the discharged group compared with the interstage inpatients (86% vs 56%, P.001). A reduced predictive model of discharge included lower gestational age (odds ratio [OR]: 0.95), lower median income for ZIP code (OR: 0.4), lower birth-weight-for-age z-score (OR: 0.56), longer cardiopulmonary bypass time (OR: 0.45), and Blalock-Taussig shunt (OR: 0.32).Survival up to 10 years after Norwood procedure is good using a strategy of inpatient care for a subset of high-risk patients to mitigate home interstage mortality. A probabilistic model used after Norwood procedure was able to predict interstage discharge with good accuracy, but will require external validation to ensure generalizability. Further work is also needed to determine optimal palliative pathways for the high-risk patients because of the notable attrition beyond successful bidirectional Glenn procedure. |
Databáze: | OpenAIRE |
Externí odkaz: |